You have 9 free searches left this month | for more free features.

AML

Showing 1 - 25 of 2,521

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Essential Hypertension Trial (AZM X mg + AML Y mg, AZM X mg + AML Y' mg, AZM X' mg + AML Y mg)

Not yet recruiting
  • Essential Hypertension
  • AZM X mg + AML Y mg
  • +7 more
  • (no location specified)
May 25, 2022

AML Trial in Wuhan (CAR--?dT cells)

Recruiting
  • AML
  • CAR--γδT cells
  • Wuhan, Hubei, China
    Tongji Hospital
May 24, 2022

MDS, AML Trial in Bronx (Venetoclax, Decitabine)

Recruiting
  • MDS
  • AML
  • Bronx, New York
    Montefiore Medical Center
Jul 22, 2022

Acute Myeloid Leukemia Trial in Baltimore (Decitabine, talazoparib)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Baltimore, Maryland
    University of Maryland Greenebaum Comprehensive Cancer Center
May 31, 2022

Acute Myelogenous Leukemia Trial in Boston (decitabine, DC/AML fusion cells)

Recruiting
  • Acute Myelogenous Leukemia
  • Boston, Massachusetts
  • +1 more
Nov 15, 2021

AML, Acute Myeloid Leukemia Trial in Boston (DREAMLAND, CERENA)

Not yet recruiting
  • AML
  • Acute Myeloid Leukemia
  • DREAMLAND
  • CERENA
  • Boston, Massachusetts
    Massachusetts General Hospital
Aug 12, 2022

Acute Myeloid Leukemia, Relapsed Adult AML Trial (Lintuzumab-Ac225, Venetoclax, Azacitidine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Relapsed Adult AML
  • Lintuzumab-Ac225
  • +2 more
  • (no location specified)
Feb 22, 2022

Acute Myeloid Leukemia (AML) Trial in San Francisco (Niclosamide)

Not yet recruiting
  • Acute Myeloid Leukemia (AML)
  • San Francisco, California
    Stanford University
Jun 8, 2022

Acute Myelogenous Leukemia, AML Trial in Boston (DC AML Vaccine)

Active, not recruiting
  • Acute Myelogenous Leukemia
  • AML
  • DC AML Vaccine
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Jan 25, 2022

Healthcare Resource Utilization in Adults Diagnosed With Acute

Completed
  • Acute Myeloid Leukemia (AML)
  • Helsinki, Finland
    Novartis Investigative Site
Aug 3, 2022

Acute Myeloid Leukemia (AML) in Remission Trial in Suzhou (Azacitidine, Venetoclax, Supportive care)

Not yet recruiting
  • Acute Myeloid Leukemia (AML) in Remission
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University, Jiangsu Ins
Jun 3, 2022

Patterns and Key Healthcare Resource Use in Acute Myeloid

Completed
  • Acute Myeloid Leukemia (AML)
  • Treatment patterns among AML patients
  • AML-related healthcare resources
  • Charlotte, North Carolina
    Sermo
Jan 25, 2022

Acute Myeloid Leukemia (AML) Trial in Nantes (Siltuximab)

Not yet recruiting
  • Acute Myeloid Leukemia (AML)
  • Nantes, France
    CHU de Nantes
Jan 24, 2023

CBFA2T3-GLIS2-positive Acute Myeloid Leukemia, AML, Childhood, Relapsed Pediatric AML Trial (ELU001)

Not yet recruiting
  • CBFA2T3-GLIS2-positive Acute Myeloid Leukemia
  • +3 more
  • (no location specified)
Nov 14, 2022

Adverse Events and Change in Disease Activity in Participants

Recruiting
  • Acute Myeloid Leukemia (AML)
    • Seoul, Korea, Republic of
      Korea University Anam Hospital /ID# 231022
    Mar 22, 2022

    AML, Adult Trial in Berne (HDM201, Midostaurin)

    Recruiting
    • AML, Adult
    • Berne, Switzerland
      Departement of Medical Oncology, University Hospital Berne
    Jan 27, 2022

    Implantation ofAdvanced Practice Nurse in Complex Care Pathway

    Not yet recruiting
    • Myeloid Leukemia
    • Interviews
    • (no location specified)
    Jul 13, 2022

    Acute Myeloid Leukemia (AML) in Remission Trial in Washington (CPX-351)

    Recruiting
    • Acute Myeloid Leukemia (AML) in Remission
    • Washington, District of Columbia
      Georgetown Lombardi Comprehensive Cancer Center
    May 3, 2022

    Acute Myeloid Leukemia Trial in Baltimore, Chapel Hill, Charleston (pembrolizumab, Azacitadine)

    Active, not recruiting
    • Acute Myeloid Leukemia
    • Baltimore, Maryland
    • +2 more
    May 19, 2022

    AML Trial (APVO436)

    Withdrawn
    • AML
    • APVO436
    • (no location specified)
    Nov 29, 2021

    Leukemia, Myeloid, Acute, Relapsed Adult AML, Refractory Leukemia Trial in Xiamen (venetoclax combining chidamide and

    Recruiting
    • Leukemia, Myeloid, Acute
    • +2 more
    • venetoclax combining chidamide and azacitidine (VCA)
    • Xiamen, Fujian, China
      Bing Xu
    Aug 1, 2022

    AML, Adult Trial in Hangzhou (QN-030a, Cyclophosphamid, Fludarabine)

    Recruiting
    • AML, Adult
    • Hangzhou, Zhejiang, China
      The first affiliated hospital of medical college of zhejiang uni
    Dec 29, 2022

    Acute Myeloid Leukemia Trial in Cincinnati (CIML-NK Cells)

    Recruiting
    • Acute Myeloid Leukemia
    • CIML-NK Cells
    • Cincinnati, Ohio
      Cincinnati Children's Hospital Medical Center
    Jan 4, 2023

    Newly Diagnosed Acute Myeloid Leukemia (AML) Trial in Chengdu (SKLB1028 Dose Escalation)

    Recruiting
    • Newly Diagnosed Acute Myeloid Leukemia (AML)
    • SKLB1028 Dose Escalation
    • Chengdu, China
      West China Hospital of Sichuan University
    Jun 30, 2022

    AML, Hyperleukocytosis Trial in Monterrey (Vinblastine, Hydroxyurea capsules)

    Recruiting
    • AML
    • Hyperleukocytosis
    • Monterrey, Nuevo Leon, Mexico
      Hopsital Universitario Dr. Jose E. Gonzalez, Centro Universitari
    Oct 9, 2021